The FY20 RCRP RCDA supports the development of resources to advance the field of rare cancers research and ultimately improve outcomes for individuals with rare cancers.

Major gaps in patient care of rare cancers include lack of communication and dissemination strategies for rare cancer research

credit:

and clinical findings within communities; lack of therapeutics and mechanistic studies to inform treatment development; lack of research and clinical resources including patient tissues, cell, and tumor models; and lack of infrastructure for sharing data and other resources.

The intent of this funding opportunity is to develop platforms that can share resources and knowledge pertaining to available models, molecular pathways, and therapeutic approaches to facilitate collaboration and information sharing among stakeholders such as researchers, patients, caregivers, clinicians, and other members of the rare cancers community.